Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3014)
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
GARNETT KEITHLY — CFO
Shares
257
Price
$3.89
Total Value
$1.00K
Shares Held After
242,357
% of Holdings
0.1%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
15,000
Price
$3.96
Total Value
$59.40K
Shares Held After
3,148,000
% of Holdings
0.5%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CHEN THOMAS C — Director
Shares
5,242
Price
$3.81
Total Value
$20.00K
Shares Held After
24,503
% of Holdings
21.4%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Chief Technology and Manufacturing Officer
Shares
2,587
Price
$1.93
Total Value
$4.99K
Shares Held After
509,198
% of Holdings
0.5%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance&Operations
Shares
1,658
Price
$1.93
Total Value
$3.20K
Shares Held After
502,907
% of Holdings
0.3%
Inhibrx Biosciences, Inc. (INBX)
MANHARD KIMBERLY — Director
Shares
500
Price
$110.26
Total Value
$55.13K
Shares Held After
8,000
% of Holdings
5.9%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$73.44
Total Value
$550.80K
Shares Held After
377,820
% of Holdings
1.9%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Ben Yong — Director
Shares
2,000
Price
$7.84
Total Value
$15.68K
Shares Held After
9,383
% of Holdings
17.6%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
9,943
Price
$98.37
Total Value
$978.09K
Shares Held After
44,745
% of Holdings
18.2%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
6,602
Price
$14.12
Total Value
$93.22K
Shares Held After
132,650
% of Holdings
4.7%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
31,888
Price
$14.12
Total Value
$450.26K
Shares Held After
640,610
% of Holdings
4.7%
Liquidia Corp (LQDA)
SINGH RAMAN — Director
Shares
8,468
Price
$66.16
Total Value
$560.24K
Shares Held After
44,637
% of Holdings
15.9%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
10,000
Price
$22.65
Total Value
$226.50K
Shares Held After
792,923
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
Mesa Nilda — Director
Shares
98
Price
$505.98
Total Value
$49.59K
Shares Held After
5,580
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
Mesa Nilda — Director
Shares
130
Price
$505.79
Total Value
$65.75K
Shares Held After
6,430
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$506.48
Total Value
$222.85K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,400
Price
$505.25
Total Value
$1.21M
Shares Held After
324,883
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,722
Price
$504.47
Total Value
$1.37M
Shares Held After
327,283
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,358
Price
$503.44
Total Value
$1.19M
Shares Held After
330,005
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,580
Price
$502.15
Total Value
$793.40K
Shares Held After
332,363
% of Holdings
0.5%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
5,900
Price
$0.22
Total Value
$1.29K
Shares Held After
69,822
% of Holdings
8.5%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
2,291
Price
$39.40
Total Value
$90.28K
Shares Held After
128,334
% of Holdings
1.8%
MAIA Biotechnology, Inc. (MAIA)
Vitoc Vlad — Director
Shares
73,000
Price
$1.37
Total Value
$100.01K
Shares Held After
1,049,121
% of Holdings
7.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
2,300
Price
$105.19
Total Value
$241.94K
Shares Held After
239,258
% of Holdings
1.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
1,817
Price
$104.55
Total Value
$189.96K
Shares Held After
241,558
% of Holdings
0.7%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
8,698
Price
$103.43
Total Value
$899.63K
Shares Held After
243,375
% of Holdings
3.5%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
30,746
Price
$102.35
Total Value
$3.15M
Shares Held After
252,073
% of Holdings
10.9%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
6,439
Price
$101.75
Total Value
$655.15K
Shares Held After
282,819
% of Holdings
2.2%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
41,000
Price
$99.45
Total Value
$4.08M
Shares Held After
602,209
% of Holdings
6.4%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)
He Junli — Director
Shares
361,905
Price
$1.05
Total Value
$380.00K
Shares Held After
1,326,205
% of Holdings
27.3%
TENAX THERAPEUTICS, INC. (TENX)
Giordano Christopher Thomas — Director
Shares
6,000
Price
$1.88
Total Value
$11.25K
Shares Held After
17,324
% of Holdings
34.6%
TENAX THERAPEUTICS, INC. (TENX)
STAAB THOMAS R II — Chief Financial Officer
Shares
5,675
Price
$1.94
Total Value
$10.98K
Shares Held After
15,675
% of Holdings
36.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
1,274
Price
$153.06
Total Value
$195.00K
Shares Held After
175,245
% of Holdings
0.7%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
4,577
Price
$151.72
Total Value
$694.40K
Shares Held After
176,519
% of Holdings
2.5%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
6,520
Price
$150.62
Total Value
$982.04K
Shares Held After
181,096
% of Holdings
3.5%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CHEN THOMAS C — Director
Shares
5,556
Price
$3.60
Total Value
$20.00K
Shares Held After
19,261
% of Holdings
28.8%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
75,364
Price
$3.40
Total Value
$256.46K
Shares Held After
598,489
% of Holdings
11.2%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
200
Price
$94.02
Total Value
$18.80K
Shares Held After
15,312
% of Holdings
1.3%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
2,208
Price
$93.26
Total Value
$205.92K
Shares Held After
15,512
% of Holdings
12.5%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
4,051
Price
$92.41
Total Value
$374.37K
Shares Held After
17,720
% of Holdings
18.6%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
3,000
Price
$91.11
Total Value
$273.32K
Shares Held After
21,771
% of Holdings
12.1%
Inhibrx Biosciences, Inc. (INBX)
MANHARD KIMBERLY — Director
Shares
500
Price
$111.78
Total Value
$55.89K
Shares Held After
8,500
% of Holdings
5.6%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Shares
3,270
Price
$205.81
Total Value
$672.99K
Shares Held After
291,876
% of Holdings
1.1%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Shares
4,995
Price
$204.84
Total Value
$1.02M
Shares Held After
295,146
% of Holdings
1.7%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Shares
17,949
Price
$203.87
Total Value
$3.66M
Shares Held After
300,141
% of Holdings
5.6%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Shares
18,869
Price
$203.06
Total Value
$3.83M
Shares Held After
318,090
% of Holdings
5.6%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Shares
21,447
Price
$201.75
Total Value
$4.33M
Shares Held After
336,959
% of Holdings
6.0%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Shares
13,368
Price
$200.78
Total Value
$2.68M
Shares Held After
358,406
% of Holdings
3.6%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Shares
11,833
Price
$200.11
Total Value
$2.37M
Shares Held After
371,774
% of Holdings
3.1%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Shares
800
Price
$198.55
Total Value
$158.84K
Shares Held After
383,607
% of Holdings
0.2%
Showing 251–300 of 3014 transactions (page 6 of 61)